Rahil Dharia, MD
MOHS-Micrographic Surgery · Glendale, CANPI 1821524901
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.1% of the total across 528 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 15.4% — the pattern of someone who eats at a lot of different presentations. Among mohs-micrographic surgery clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 528 payments — averaging $24.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Sanofi$2K
- Incyte Corporation$1K
- Lilly USA, LLC$978
- Novartis$801
- Sun Pharmaceutical Industries Inc.$708
- plus $5K from 24 others
What the payments were for
- Consulting fees$3503%
- Travel & lodging$40%
- Food & beverage$12,17595%
- Education$2682%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 115 | $1,974 |
| Sanofi | 46 | $1,854 |
| Incyte Corporation | 53 | $1,049 |
| Lilly USA, LLC | 54 | $978 |
| Novartis | 30 | $801 |
| Sun Pharmaceutical Industries Inc. | 39 | $708 |
| Regeneron Healthcare Solutions, Inc. | 22 | $698 |
| Johnson & Johnson | 18 | $647 |
| Galderma Laboratories, L.p. | 11 | $513 |
| Pfizer | 22 | $479 |
| Medimetriks Pharmaceuticals, Inc. | 6 | $472 |
| UCB, Inc. | 10 | $383 |
| Dermavant Sciences, Inc. | 20 | $316 |
| LEO Pharma Inc. | 12 | $251 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 14 | $242 |
| Arcutis Biotherapeutics, Inc. | 11 | $240 |
| Strata Skin Sciences, Inc. | 4 | $214 |
| Amgen | 9 | $206 |
| Mayne Pharma Commercial LLC | 13 | $146 |
| Medtronic | 1 | $132 |
| Saluda Medical Americas, Inc. | 1 | $117 |
| Boehringer Ingelheim | 3 | $72 |
| Journey Medical Corporation | 2 | $60 |
| EPI Health, LLC | 3 | $54 |
| Organon | 2 | $49 |
| Smith+Nephew | 1 | $39 |
| Fresenius Kabi USA, LLC | 2 | $39 |
| Almirall LLC | 2 | $32 |
| E.r. Squibb & Sons, L.L.C. | 1 | $20 |
| Sanofi-aventis U.S. LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Neo-Synalar$350
- Tovet (emollient formulation)$350
- DUPIXENT$236
- NEMLUVIO$154
- INTELLIS ADAPTIVESTIM$132
- Skyrizi$125
- EBGLYSS$122
- COSENTYX$119
- Tremfya$118
- Evoke$117
- BOTOX$113
- LITFULO$106
How this compares
$12,797 in reported general payments places this provider in the 90th percentile of 144 mohs-micrographic surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 12 | $45,107 |
| Clobetasol Propionate | 87 | $2,973 |
| Fluorouracil | 42 | $2,811 |
| Doxycycline Hyclate | 113 | $1,144 |
| Triamcinolone Acetonide | 126 | $992 |
| Metronidazole | 19 | $921 |
| Ketoconazole | 58 | $830 |
| Hydrocortisone | 62 | $537 |
| Clindamycin Phosphate | 17 | $495 |
| Mupirocin | 92 | $477 |
| Ciclopirox | 14 | $259 |
| ValacyclovirValacyclovir Hcl | 11 | $67 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Glendale
- Sarah ArronBurlingame$98K
- Daniel Zelacla Jolla$43K
- Ralph MasseySanta Monica$38K
- Michael MortazieOrange$29K
- Sumaira AasiStanford$27K
- Andrea WilleySacramento$21K
- Benjamin Kelleyla Jolla$20K
- Frank NoodlemanSaratoga$19K
- Howard FeinRolling Hills Estates$19K
- Joanna ChanLong Beach$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.